Hüseyin Aytuğ Avşar

Hüseyin Aytuğ Avşar

Auto-generated profile, based on publicly available information

Hüseyin Aytuğ Avşar

Department of Obstetrics and Gynecology Tinaztepe University School of Medicine Galen Hospital Izmir Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
CACan Ata
Can Ata
SESelcuk Erkılınc
Selcuk Erkılınc

10 June 2024 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
OYONUR YAVUZ
ONUR YAVUZ
HAHüseyin Aytuğ Avşar
Hüseyin Aytuğ Avşar
CACan Ata
Can Ata
SESelçuk Erkılınç
Selçuk Erkılınç
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
Vitamin D evaluation in adenomyosis: A retrospective cross-sectional study - Turkish Journal of Obstetrics and Gynecology

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
SESelçuk Erkılınç
Selçuk Erkılınç
OYONUR YAVUZ
ONUR YAVUZ
HAHüseyin Aytuğ Avşar
Hüseyin Aytuğ Avşar
CACan Ata
Can Ata
Aim: It is very important to uncover the relationship between Hydrosalpinx, which occurs as a result of chronic-inflammatory-processes, and inflammatory markers. Our study aimed to investigate the role of Neutrophil/Lymphocyte Ratio(NLR), Platelet/Lymphocyte Ratio(PLR), and Mean Platelet Volume(MPV) values in the diagnosis of patients who had Hydrosalpinx. Materials and Methods: Our study included 349 patients, who applied to our clinic between March 2018-June 2023, were diagnosed with primary or secondary infertility, and for this reason underwent Hysterosalpingography. A total of 89 patients who had Hydrosalpinx and 260 patients who did not have Hydrosalpinx were divided into 2 groups, and the demographic, clinical data were compared retrospectively. Results: Neutrophil and Platelet levels were found to be significantly higher in the Hydrosalpinx-group than the control group(p:0.000).The presence of Hydrosalpinx was found to be significantly higher in patients who were diagnosed with secondary infertility(p:0.000).Neutrophil and Platelet levels were significantly higher in the bilateral-Hydrosalpinx-group than the unilateral-Hydrosalpinx-group(p:0.036,p:0.012, respectively). The NLR and PLR were found to be significantly higher in the bilateral-Hydrosalpinx-group than the unilateral–Hydrosalpinx-group(p:0.038,p:0.009, respectively). MPV were found to be significantly lower in the bilateral-Hydrosalpinx-group than the unilateral-Hydrosalpinx-group(p:0.011). Conclusion: The findings of our study support the literature data on the relationship between NLR,PLR,MPV, and chronic inflammatory processes. These markers deserve to be evaluated again and again in prospective and controlled studies, in which they will be considered together with clinical findings, to investigate their ability to predict the diagnosis of Hydrosalpinx, its severity, and clinical outcomes in infertile patients.

23 March 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
OYONUR YAVUZ
ONUR YAVUZ
BEBurak Ersak
Burak Ersak
CACan Ata
Can Ata
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
USUlas Solmaz
Ulas Solmaz

24 September 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
CACan Ata
Can Ata
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
OYONUR YAVUZ
ONUR YAVUZ
SESelcuk Erkilinc
Selcuk Erkilinc
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
Polycystic ovary syndrome (PCOS) is an endocrine disorder prevalent in around 6–8% of women in their reproductive years. The measurement of Anti-Müllerian Hormone (AMH) holds particular promise in discerning both the diagnosis and the extent of severity in PCOS cases. This study aims to evaluate the effectiveness of using AMH as a potential tool for identifying and diagnosing the severity of clinical aspects associated with the syndrome. A retrospective analysis was performed on 309 female patients who presented for consultation at our hospital’s gynecology outpatient clinic and were diagnosed with PCOS based on the Rotterdam criteria, between January 2018 and March 2022. Data were extracted from the hospital database and systematically assessed. Patients were divided into two groups based on the mean AMH level of 7.5 ng/mL, allowing comparison between higher and lower AMH subgroups. Clinical symptoms and findings were assessed based on AMH values. A statistically significant difference was observed between groups for the mean levels of total testosterone, androstenedione, free androgen index, luteinizing hormone, and follicle-stimulating hormone (p < 0.05). Additionally, a statistically significant difference was noted between AMH groups and the presence of oligomenorrhea (p < 0.05). Even at the higher end of the spectrum, AMH retains significant value in determining the clinical aspects of PCOS.

27 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CACan Ata
Can Ata
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
SESelcuk Erkilinc
Selcuk Erkilinc
Endometrial atypical hyperplasia is recognized as a precursor to endometrial cancer, which ranks as the fourth most common cancer in women and is the leading type of gynecological malignancy in high-income countries. The development and progression of endometrial cancer are strongly linked to increased body fat and insulin resistance. Peptides involved in glucose metabolism, such as leptin, chemerin, and galanin, may contribute to carcinogenesis through shared pathways. This study aims to investigate the role of galanin levels in diagnosing endometrial neoplastic disorders. This prospective case-control study included 85 patients, divided into three groups: endometrial cancer, atypical hyperplasia, and a control group. Serum galanin levels were measured using ELISA across all groups. The mean galanin levels were 472.76 ± 44.86 pg/ml in Control Group, 516.81 ± 51.15 pg/ml in EAH, and 543.15 ± 73.22 pg/ml in Cancer Group. Galanin levels were found to be significantly different among groups. (p < .001) . Galanin levels have the potential to differentiate between normal endometrium and patients with endometrial hyperplasia.